https://orcid.org/0000-0003-2953-210X
Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Amir Hossein Miri, Mojtaba Kamankesh, Mazda Rad-Malekshahi, Abbas Yadegar, Maryam Banar, Michael R. Hamblin, Ismaeil Haririan, Hamid Asadzadeh Aghdaei & Mohammad Reza Zali. (2023) Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal against Helicobacter pylori. Expert Review of Anti-infective Therapy 21:6, pages 617-639.
Read now
Read now
Anna-Klara Pettersson, Giola Santoni, Jacinth Yan, Cecilia Radkiewicz, Shaohua Xie, Helgi Birgisson, Eivind Ness-Jensen, My von Euler-Chelpin, Joonas H. Kauppila & Jesper Lagergren. (2023) Cohort profile: Nordic Helicobacter Pylori eradication project (NordHePEP). Scandinavian Journal of Gastroenterology 58:5, pages 453-459.
Read now
Read now
Ali Nabavi-Rad, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Abbas Yadegar, Sinéad Marian Smith & Mohammad Reza Zali. (2022) The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. Gut Microbes 14:1.
Read now
Read now
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo & Luís D. R. Melo. (2022) Helicobacter pylori infection: from standard to alternative treatment strategies. Critical Reviews in Microbiology 48:3, pages 376-396.
Read now
Read now
Esmat Abdi, Saeid Latifi-Navid, Fatemeh Abedi Sarvestani & Mohammad Hassan Esmailnejad. (2021) Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opinion on Therapeutic Targets 25:8, pages 685-699.
Read now
Read now
Articles from other publishers (38)
Meng Li, Ning Gao, Shaoli Wang, Yufeng Guo & Zhen Liu. (2023)
Bibliometric analysis of
Helicobacter pylori
resistance—from 2002 to 2022
. Helicobacter 28:4.
Crossref
Crossref
Hao Wu, Qingyue Sun, Huirong Dong, Jiasen Qiao, Ying lin, Chen Yu & Yanni Li. (2023) Gastroprotective action of the extract of Corydalis yanhusuo in Helicobacter pylori infection and its bioactive component, dehydrocorydaline. Journal of Ethnopharmacology 307, pages 116173.
Crossref
Crossref
Chia‐Chu Yeh, Chieh‐Chang Chen, Chien‐Chuan Chen, Ming‐Lun Han, Jia‐Feng Wu, Hsiu‐Po Wang, Ming‐Shiang Wu & Ping‐Huei Tseng. (2023) Characteristics of the esophageal microbiome in patients with achalasia and its changes before and after peroral endoscopic myotomy: A pilot study. Journal of Gastroenterology and Hepatology.
Crossref
Crossref
Peter Malfertheiner, M. Constanza Camargo, Emad El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I. Smith & Sebastian Suerbaum. (2023) Helicobacter pylori infection. Nature Reviews Disease Primers 9:1.
Crossref
Crossref
Marcello Fiorani, Ege Tohumcu, Livio Enrico Del Vecchio, Serena Porcari, Giovanni Cammarota, Antonio Gasbarrini & Gianluca Ianiro. (2023) The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota. Antibiotics 12:4, pages 765.
Crossref
Crossref
Ilmārs Stonāns, Jelizaveta Kuzmina, Inese Poļaka, Solveiga Grīnberga, Eduards Sevostjanovs, Edgars Liepiņš, Ilona Aleksandraviča, Daiga Šantare, Arnis Kiršners, Roberts Škapars, Andrejs Pčolkins, Ivars Tolmanis, Armands Sīviņš, Mārcis Leja & Maija Dambrova. (2023) The Association of Circulating L-Carnitine, γ-Butyrobetaine and Trimethylamine N-Oxide Levels with Gastric Cancer. Diagnostics 13:7, pages 1341.
Crossref
Crossref
Catarina Lopes, Tatiana C. Almeida, Pedro Pimentel-Nunes, Mário Dinis-Ribeiro & Carina Pereira. (2023) Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging. Frontiers in Immunology 14.
Crossref
Crossref
Yue-Hua Zhang, Xiao-Lin Chen, Yi-Ran Wang, Yu-Wei Hou, Yao-Dong Zhang & Kai-Juan Wang. (2023) Prevention of malignant digestive system tumors should focus on the control of chronic inflammation. World Journal of Gastrointestinal Oncology 15:3, pages 389-404.
Crossref
Crossref
Ana Bačić, Vladimir Milivojević, Isidora Petković, Dušan Kekić, Ina Gajić, Branislava Medić Brkić, Dušan Popadić, Tomica Milosavljević & Mirjana Rajilić-Stojanović. (2023) In Search for Reasons behind Helicobacter pylori Eradication Failure–Assessment of the Antibiotics Resistance Rate and Co-Existence of Helicobacter pylori with Candida Species. Journal of Fungi 9:3, pages 328.
Crossref
Crossref
Xinyuan Cao, Yingyun Yang, Yizhen Zhang, Ruoyu Ji, Xinyu Zhao, Weiyang Zheng & Aiming Yang. (2023)
Impact of
Helicobacter pylori
on the gastric microbiome in patients with chronic gastritis: a systematic review and meta-analysis protocol
. BMJ Open 13:3, pages e050476.
Crossref
Crossref
Hang Yang, Yi Mou & Bing Hu. (2022)
Discussion on the common controversies of
Helicobacter pylori
infection
. Helicobacter 28:1.
Crossref
Crossref
Chuan-Guo Guo, Feifei Zhang, Fang Jiang, Lingling Wang, Yijun Chen, Wenxue Zhang, Anni Zhou, Shutian Zhang & Wai K. Leung. (2023)
Long-term effect of
Helicobacter pylori
eradication on colorectal cancer incidences
. Therapeutic Advances in Gastroenterology 16, pages 175628482311709.
Crossref
Crossref
Elke Burgermeister & Matthias P. Ebert. 2023. Microbiome in Gastrointestinal Cancer. Microbiome in Gastrointestinal Cancer
41
66
.
Natsuda Aumpan, Varocha Mahachai & Ratha‐korn Vilaichone. (2022)
Management of
Helicobacter pylori
infection
. JGH Open 7:1, pages 3-15.
Crossref
Crossref
Meng-Yan Cui, Zhen-Yu Cui, Meng-Qi Zhao, Meng-Jie Zhang, Qiao-Li Jiang, Jing-Jing Wang, Lun-Gen Lu & Ying-Ying Lu. (2022) The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota. BMC Microbiology 22:1.
Crossref
Crossref
Fabrício Freire de Melo, Hanna Santos Marques, Samuel Luca Rocha Pinheiro, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Kádima Nayara Teixeira, Cláudio Lima Souza & Márcio Vasconcelos Oliveira. (2022)
Influence of
Helicobacter pylori
oncoprotein CagA in gastric cancer: A critical-reflective analysis
. World Journal of Clinical Oncology 13:11, pages 866-879.
Crossref
Crossref
Jamshid Gholizadeh Navashenaq, Arezoo Gowhari Shabgah, Maciej Banach, Tannaz Jamialahmadi, Peter E. Penson, Thomas P. Johnston & Amirhossein Sahebkar. (2022) The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis. Seminars in Cancer Biology 86, pages 951-959.
Crossref
Crossref
Yi Hu, Xin Xu, Yao‐Bin Ouyang, Cong He, Nian‐Shuang Li, Chuan Xie, Chao Peng, Zhen‐Hua Zhu, Yong Xie, Xu Shu, Nong‐Hua Lu & Yin Zhu. (2022)
Analysis of oral microbiota alterations induced by
Helicobacter pylori
infection and vonoprazan‐amoxicillin dual therapy for
Helicobacter pylori
eradication
. Helicobacter 27:5.
Crossref
Crossref
Marisol Villalva, Jose Manuel Silvan, Teresa Alarcón-Cavero, David Villanueva-Bermejo, Laura Jaime, Susana Santoyo & Adolfo J. Martinez-Rodriguez. (2022) Antioxidant, Anti-Inflammatory, and Antibacterial Properties of an Achillea millefolium L. Extract and Its Fractions Obtained by Supercritical Anti-Solvent Fractionation against Helicobacter pylori. Antioxidants 11:10, pages 1849.
Crossref
Crossref
Peng Huang, Jianwei Cao, Jingyi Chen, Yanrong Luo, Xiaofang Gong, Chengyi Wu & Yu Wang. (2022) Crosstalk between gut microbiota and renal ischemia/reperfusion injury. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Shahid Aziz, Faisal Rasheed, Tayyab Saeed Akhter, Rabaab Zahra & Simone König. (2022) Microbial Proteins in Stomach Biopsies Associated with Gastritis, Ulcer, and Gastric Cancer. Molecules 27:17, pages 5410.
Crossref
Crossref
Wenting Xu, Liming Xu & Chengfu Xu. (2022) Relationship between Helicobacter pylori infection and gastrointestinal microecology. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Farzaneh Fakharian, Behnoush Asgari, Ali Nabavi-Rad, Amir Sadeghi, Neda Soleimani, Abbas Yadegar & Mohammad Reza Zali. (2022) The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Junjian He, Yunyi Liu, Qin Ouyang, Rongxing Li, Jie Li, Weiyan Chen, Weichao Hu, Lijiao He, Qiyu Bao, Ping Li & Changjiang Hu. (2022) Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications. Frontiers in Microbiology 13.
Crossref
Crossref
Xi Chen, Nanxi Wang, Jiannan Wang, Binyou Liao, Lei Cheng & Biao Ren. (2022) The interactions between oral-gut axis microbiota and Helicobacter pylori. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Cong He, Chao Peng, Xinbo Xu, Nianshuang Li, Yaobin Ouyang, Yin Zhu & Nonghua Lu. (2022) Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota. Helicobacter 27:4.
Crossref
Crossref
Bing Chen, Xin-meng Li, Ting Cai & Fen Wang. (2022) Short-term and long-term alterations of gastrointestinal microbiota with different H. pylori eradication regimens: A meta-analysis. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Xu Shu, Yong Xie, Nong-Hua Lu & Yin Zhu. (2022) Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Paul Oster, Laurie Vaillant, Brynn McMillan & Dominique Velin. (2022) The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection. Frontiers in Immunology 13.
Crossref
Crossref
Chan Hyuk Park. (2022) A Step Toward Discovering the New World of Esophageal Microbiota. Journal of Neurogastroenterology and Motility 28:2, pages 167-168.
Crossref
Crossref
Paul Oster, Laurie Vaillant, Erika Riva, Brynn McMillan, Christina Begka, Caroline Truntzer, Corentin Richard, Marine M Leblond, Meriem Messaoudene, Elisavet Machremi, Emeric Limagne, Francois Ghiringhelli, Bertrand Routy, Gregory Verdeil & Dominique Velin. (2022)
Helicobacter pylori
infection has a detrimental impact on the efficacy of cancer immunotherapies
. Gut 71:3, pages 457-466.
Crossref
Crossref
Stanislav Sitkin, Leonid Lazebnik, Elena Avalueva, Svetlana Kononova & Timur Vakhitov. (2022)
Gastrointestinal microbiome and
Helicobacter pylori
: Eradicate, leave it as it is, or take a personalized benefit–risk approach?
. World Journal of Gastroenterology 28:7, pages 766-774.
Crossref
Crossref
Yuanbin Liu & Mingkai Chen. (2022) Insights into the underlying mechanisms and clinical management of microscopic colitis in relation to other gastrointestinal disorders. Gastroenterology Report 10.
Crossref
Crossref
Karolina Kaźmierczak-Siedlecka, Agnieszka Daca, Giandomenico Roviello, Martina Catalano & Karol Połom. (2021) Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?. Gastric Cancer 25:1, pages 1-10.
Crossref
Crossref
Jose Manuel Silvan, Esperanza Guerrero-Hurtado, Alba Gutiérrez-Docio, Teresa Alarcón-Cavero, Marin Prodanov & Adolfo J. Martinez-Rodriguez. (2021) Olive-Leaf Extracts Modulate Inflammation and Oxidative Stress Associated with Human H. pylori Infection. Antioxidants 10:12, pages 2030.
Crossref
Crossref
E. B. Avalueva, M. Yu. Serkova & S. I. Sitkin. (2021) <i>Helicobacter pylori</i>. The survival strategy of a commensal symbiont in the <i>Homo sapiens</i> population. Experimental and Clinical Gastroenterology:9, pages 102-108.
Crossref
Crossref
Hang Yang, Bin Wei & Bing Hu. (2021) Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflammation Research 70:10-12, pages 1015-1026.
Crossref
Crossref
Pavol Sulo & Barbora Šipková. (2021)
DNA diagnostics for reliable and universal identification of
Helicobacter pylori
. World Journal of Gastroenterology 27:41, pages 7100-7112.
Crossref
Crossref